文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

表观扩散系数值预测大块宫颈癌近距离放疗反应

Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.
PubMed 文献 · Radiat Oncol · 2024-03-13

研究纳入45例接受组织间近距离放疗且高危临床靶体积>30 cc的大块宫颈癌患者,评估外照射后、近距离放疗前DWI所得90百分位ADC值预测完全代谢反应(CMR)的能力。28例(62%)达到CMR;单因素分析仅90百分位ADC值与CMR显著相关(p=0.029),多因素分析中90百分位ADC(p<0.0001)与HR-CTV大小(p<0.003)均高度显著。90百分位ADC值高于2.10×10^-3 mm2/s的患者达到CMR的可能性为5.33倍(95%CI 1.35-24.4)。

要点

  • 45例大块宫颈癌患者中28例(62%)达到CMR。
  • 单因素分析仅90百分位ADC值与CMR显著相关(p=0.029)。
  • 90百分位ADC值高于2.10×10^-3 mm2/s者达到CMR的可能性为5.33倍(95%CI 1.35-24.4)。

核心结论

  • 临床DWI或可用于接受组织间近距离放疗的大块宫颈癌患者的风险分层。

研究设计与样本

  • 研究获取接受组织间近距离放疗且HR-CTV>30 cc患者的临床与DWI(b值=500 s/mm2)数据。
  • 在共配准T2加权图像上勾画体积并计算90百分位ADC值,按近距离放疗后3个月PET-CT定义的CMR进行分层。
  • 采用单因素和多因素logistic回归分析CMR与90百分位ADC值及其他临床因素的关系,并用约登J统计量确定阈值。

主要发现

  • 45例患者中28例(62%)达到CMR。
  • 单因素分析中仅90百分位ADC值与CMR显著相关(p=0.029),其他影像和临床因素均不显著。
  • HR-CTV大小(p=0.054)和化疗周期数(p=0.078)为边缘显著因素。
  • 多因素分析中90百分位ADC(p<0.0001)和HR-CTV大小(p<0.003)均高度显著。
  • 90百分位ADC值高于2.10×10^-3 mm2/s的患者达到CMR的可能性为5.33倍(95%CI 1.35-24.4)。

关键数值与推荐

  • CMR定义为近距离放疗后3个月PET-CT所示完全代谢反应。
  • 90百分位ADC值阈值2.10×10^-3 mm2/s由约登J统计量确定。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diffusion-weighted magnetic resonance imaging (DWI) provides a measurement of tumor cellularity. We evaluated the potential of apparent diffusion coefficient (ADC) values obtained from post-external beam radiation therapy (EBRT) DWI and prior to brachytherapy (BT) to predict for complete metabolic response (CMR) in bulky cervical cancer. METHODS: Clinical and DWI (b value = 500 s/mm2) data were obtained from patients undergoing interstitial BT with high-risk clinical target volumes (HR-CTVs) > 30 cc. Volumes were contoured on co-registered T2 weighted images and 90th percentile ADC values were calculated. Patients were stratified by CMR (defined by PET-CT at three months post-BT). Relation of CMR with 90th percentile ADC values and other clinical factors (International Federation of Gynecology and Obstetrics (FIGO) stage, histology, tumor and HR-CTV size, pre-treatment hemoglobin, and age) was assessed both in univariate and multivariate logistic regression analyses. Youden's J statistic was used to identify a threshold value. RESULTS: Among 45 patients, twenty-eight (62%) achieved a CMR. On univariate analysis for CMR, only 90th percentile ADC value was significant (p = 0.029) while other imaging and clinical factors were not. Borderline significant factors were HR-CTV size (p = 0.054) and number of chemotherapy cycles (p = 0.078). On multivariate analysis 90th percentile ADC (p < 0.0001) and HR-CTV size (p < 0.003) were highly significant. Patients with 90th percentile ADC values above 2.10 × 10- 3 mm2/s were 5.33 (95% CI, 1.35-24.4) times more likely to achieve CMR. CONCLUSIONS: Clinical DWI may serve to risk-stratify patients undergoing interstitial BT for bulky cervical cancer.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Dong EE, Xu J, Kim JW, et al. Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer. Radiat Oncol. 2024. PMID: 38481285. doi:10.1186/s13014-024-02425-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。